[Deaths, Burned Clinics - What’s Different About Ebola’s 2026 Return?](https://wbbsec.com/opinions-and-features/deaths-burned-clinics-whats-different-about-ebolas-2026-return-published-in-forbes/)
[Deaths, Burned Clinics - What’s Different About Ebola’s 2026 Return?](https://wbbsec.com/opinions-and-features/deaths-burned-clinics-whats-different-about-ebolas-2026-return-published-in-forbes/)
  •   (858) 592-9901
  •   [email protected]
WBB Securities, LLCWBB Securities, LLC
  • Our Firm
    • The Team
    • Advisor Services
      • About the Broker-Dealer & RIA
  • Investment Banking
    • Life Sciences Sectors
    • M&A and Strategic Advisory
    • Institutional Sales
    • Equity Capital Markets
  • Research
    • Research Samples
  • News
    • Press Releases
    • Opinions & Features
    • SARS-CoV-2
    • Video Presentations
  • Asset Management
  • WBB Research Institute
WBB Securities, LLCWBB Securities, LLC
  • Our Firm
    • The Team
    • Advisor Services
      • About the Broker-Dealer & RIA
  • Investment Banking
    • Life Sciences Sectors
    • M&A and Strategic Advisory
    • Institutional Sales
    • Equity Capital Markets
  • Research
    • Research Samples
  • News
    • Press Releases
    • Opinions & Features
    • SARS-CoV-2
    • Video Presentations
  • Asset Management
  • WBB Research Institute
WBB Securities, LLCWBB Securities, LLC
  • Our Firm
    • The Team
    • Advisor Services
      • About the Broker-Dealer & RIA
  • Investment Banking
    • Life Sciences Sectors
    • M&A and Strategic Advisory
    • Institutional Sales
    • Equity Capital Markets
  • Research
    • Research Samples
  • News
    • Press Releases
    • Opinions & Features
    • SARS-CoV-2
    • Video Presentations
  • Asset Management
  • WBB Research Institute

As Tariffs Begin; What Will They Do To Drug Prices And Availability?

By:WBB SecuritiesPosted: Mar 4th, 2025In: Opinions & Features

3.4.2025 | Forbes

How will new tariffs impact drug prices and availability? In his latest Forbes article, WBB Securities’ President, Dr. Steve Brozak, examines the potential ripple effects across the pharmaceutical supply chain.

Read the full analysis here: As Tariffs Begin; What Will They Do To Drug Prices And Availability?

Recent Posts

Deaths, Burned Clinics—What’s Different About Ebola’s 2026 Return? – Published in Forbes

May 25, 2026

5 Urgent Questions After The WHO Emergency Hantavirus Meeting – Published in Forbes

May 15, 2026

Our Mental Health Crisis: RFK Jr. Faces Psychiatric Over-Prescribing – Published in Forbes

May 6, 2026

WBB Securities President Dr. Steve Brozak to Moderate ARPA-H Panel at Biotech Showcase 2026 on Federal Investment in Biotech Innovation

January 12, 2026

WBB Securities Initiates Coverage of Turn Therapeutics (Nasdaq: TTRX)

January 12, 2026

The U.S. 2026 Healthcare Cliff: When the Business Model Is the Real Risk

December 29, 2025

Previous Post

Dr. Steve Brozak, President of WBB Securities, will moderate a panel at the Biotech Showcase Conference on Wednesday, January 15, 2025, titled “The Need for Novel Responses to Disease Threats in a Fast-Changing World.”

Next Post

Pharma Dodges The Tariff Bullet—But For How Long?

20 Commerce Dr.
Ste. 135
Cranford, NJ 07016

3111 Camino Del Rio N.
Ste. 400
San Diego, CA 92108

Copyright © 2026 WBB Securities, LLC. All Rights Reserved. Member FINRA/SIPC, BrokerCheck

  • Form CRS
  • Disclosures
  • Privacy Policy
Menu Bottom